Ingredient comparison Nº 31 / Head-to-head
Retinol vs Bakuchiol
Retinol has decades of gold-standard evidence; bakuchiol is the gentler alternative when irritation or pregnancy rules retinol out.
Retinol (vitamin A) is the most clinically documented OTC anti-aging active, with RCTs showing significant improvements in wrinkles and collagen at 0.4% over 24 weeks. Its trade-off is retinoid dermatitis — dryness, peeling, stinging — especially in the first 2–8 weeks, and a firm avoidance recommendation in pregnancy. Bakuchiol is a plant-derived meroterpene phenol that is chemically unrelated to retinol but produces a retinol-like gene expression signature. A single 12-week RCT (n=44) found comparable outcomes for wrinkles and hyperpigmentation at 0.5% with significantly less irritation. The evidence base is thinner and rests on one small trial. Choose retinol if you want the deepest clinical record and can tolerate a titration period; choose bakuchiol if sensitive skin, pregnancy, or breastfeeding makes retinol inappropriate.
02 / Head-to-head
Compared dimension by dimension
Each row shows what the evidence actually says for both ingredients on that dimension. Edge = which ingredient has the stronger case, or "no clear edge" when evidence is comparable or insufficient for a call.
| Dimension | Retinol (Vitamin A) | Bakuchiol | Edge |
|---|---|---|---|
| Wrinkle & photoaging efficacy | Multiple RCTs demonstrate significant reduction in fine wrinkles, collagen increases, and glycosaminoglycan elevation at 0.3–0.4% over 24 weeks. The evidence base spans decades with independent replication. 345 | One 12-week RCT (n=44) found comparable wrinkle reduction to 0.5% retinol, but no formal non-inferiority analysis was conducted and replication is absent. Chaudhuri & Bojanowski 2014 provides gene expression support. 12 | Advantage: Retinol (Vitamin A) |
| Skin tolerability / irritation | Retinoid dermatitis (erythema, scaling, peeling) is well-documented in the first 2–8 weeks at 0.5%+. At 0.1–0.3%, irritation is less common but still occurs. Dose-dependent. 65 | In the Dhaliwal 2019 RCT, bakuchiol users had significantly less facial scaling and stinging than retinol users at equivalent 0.5% concentration. Does not require a tolerance-building titration period. 12 | Advantage: Bakuchiol |
| Strength of clinical evidence | Decades of RCTs including pivotal Kafi 2007 (n=36 elderly skin, 24 weeks), Shao 2017 (molecular), Farris 2024 pooled analysis (n=471 across 6 trials at 0.1%). Independent replication across multiple institutions. 35 | One published RCT (Dhaliwal 2019, n=44, 12 weeks) directly comparing bakuchiol to retinol.Gene expression study (Chaudhuri 2014) has supplier affiliation. No independent large-scale replication published. 1 | Advantage: Retinol (Vitamin A) |
| Time to visible results | Clinical improvements in fine wrinkling and skin texture emerge from 4–12 weeks in controlled trials. The first 2–8 weeks may be marked by retinoid dermatitis before visible improvement. 35 | The Dhaliwal 2019 RCT showed significant within-group improvements by 12 weeks.Onset data outside this single trial is not available. No head-to-head time-course data exists. 1 | No clear edge |
| Pregnancy & breastfeeding safety | Avoidance of topical retinoids during pregnancy is the standard precautionary recommendation from dermatology guidelines, despite limited evidence of teratogenic risk at cosmetic topical doses. Two large studies (Panchaud 2012, n=235; Refsum 2026, n=3.8M births) found no statistically significant increase in malformations, but the precautionary standard stands. 789 | Bakuchiol is not a retinoid and does not carry the vitamin A-related teratogenicity concern.However, no human safety data in pregnancy has been published. Safety in pregnancy is not established — it is merely not contraindicated by the retinoid-specific mechanism. | Advantage: Bakuchiol |
| Typical cost per effective dose | OTC retinol serums at 0.1–0.5% range widely from budget ($8–$20, The Ordinary, Cerave) to premium ($60–$150, Paula's Choice, SkinCeuticals Retinol 1.0). Effective concentration is well-documented so value is easy to calculate. | Bakuchiol products at 0.5–1% typically run $20–$60.As a newer, less commoditized ingredient, budget options are fewer. However, twice-daily use (the tested protocol) from one bottle may be faster to consume. | Advantage: Retinol (Vitamin A) |
03 / The decision
Which one is right for you?
Choose Retinol (Vitamin A) if…
- You want the deepest clinical track record — retinol has decades of independent RCT evidence across institutions
- You are not pregnant, not breastfeeding, and not planning to conceive in the near term
- You can commit to a 4–8 week titration period and tolerate initial dryness or flaking
- You want the largest price-versus-efficacy range — budget retinol at 0.3% is hard to beat on cost per clinically validated dose
- Your primary concern is collagen and photoaging; retinol's mechanism (RAR-mediated procollagen upregulation) is the most evidence-backed available OTC
Choose Bakuchiol if…
- You are pregnant, breastfeeding, or planning to conceive — retinol carries a precautionary avoidance recommendation; bakuchiol does not share the retinoid teratogenicity risk
- You have sensitive or reactive skin that can't tolerate retinoid dermatitis even at low concentrations
- You want to use an active in both AM and PM — bakuchiol is widely considered photostable unlike retinol (though peer-reviewed photostability data remains limited)
- You want anti-aging benefits without a mandatory titration protocol
- You are looking for a gentle introduction to an anti-aging active
Shop these actives
Buy CeraVe on Amazon $18.68 Retinol (Vitamin A) · affiliate link
Buy NEOGEN on Amazon $37.25 Bakuchiol · affiliate link
04 / Stacking
Can you use both?
Can you combine Retinol (Vitamin A) and Bakuchiol?
You can use retinol and bakuchiol in the same routine, though there is no peer-reviewed RCT evidence that combining them produces superior results to either alone. If combining: apply bakuchiol in AM (photostable), retinol in PM (photolabile). The Dhaliwal 2019 trial did not include a combination arm, so any synergy claim would be speculative.
05 / Questions
Frequently asked
- Is bakuchiol as good as retinol?
- The best available evidence is Dhaliwal et al. 2019 (PMID:29947134): a 12-week RCT (n=44) found no statistically significant difference between 0.5% bakuchiol and 0.5% retinol for wrinkle reduction and hyperpigmentation. However, this is one small trial — not the same as formal equivalence. Retinol's evidence base spans decades and multiple independent trials. The accurate reading is: bakuchiol produced comparable outcomes in one well-designed small trial with better tolerability. It is a credible alternative, not a proven equivalent. 1
- Can I use bakuchiol while pregnant?
- Bakuchiol is not a retinoid and does not carry the vitamin A-based teratogenicity concern that makes retinol a precautionary avoid during pregnancy. That said, no human safety data exists for bakuchiol use in pregnancy — the 'pregnancy-safe' label reflects the absence of a specific risk, not affirmative evidence of safety. If you are pregnant, discuss with your doctor or midwife before starting any new topical active.
- Which works faster, retinol or bakuchiol?
- Neither has a clear head-to-head time-course advantage based on current evidence. The Dhaliwal 2019 RCT measured outcomes at 12 weeks for both, showing comparable improvements. Retinol's first weeks are often marked by retinoid dermatitis before visible improvement appears, which can make it feel slower. Bakuchiol does not require this adjustment period. Beyond that, onset data is insufficient to draw a firm conclusion. 1
06 / References
Sources
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9